Several papers have reported potentiation of TRPV1 responses through PKC-mediated pathways [16,22,23], and PKC-potentiated TRPV1 responses have been shown to contribute to diabetic neuropathy [24]. Here, TRPV1 is linked to diabetic neuropathy.